(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ : 2021-02-18±³À°ÀÏÀÚ : 2021-02-18
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 90¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í ¼¹ö °ü°è»ó 90¸í±îÁö¸¸ °¡´ÉÇÕ´Ï´Ù.!
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 18ÀÏ A 17:00~18:00 Management of MRD positive ALL Gökbuget Nicola(University Hospital Frankfurt Germany)
±³À°½Ã°£ 02¿ù 18ÀÏ A 18:00~18:40 Extramedullary relapse in the era of immunotherapy ±èµ¿À±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02¿ù 18ÀÏ A 18:40~19:20 Dyskeratosis Congenita ±èÇö¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 18ÀÏ A 19:20~20:00 RRMM with extramedullary relapse °í¿µÀÏ(¼¿ïÀÇ´ë)